VentriPoint Diagnostics Ltd. (VPT.V)
CAD 0.14
(3.85%)
CAD 0.14
(3.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -4.73 Million CAD | -2.75% |
| 2022 | -4.78 Million CAD | -33.66% |
| 2021 | -3.7 Million CAD | -122.69% |
| 2020 | -1.57 Million CAD | 49.22% |
| 2019 | -3.04 Million CAD | 17.44% |
| 2018 | -3.79 Million CAD | -17.72% |
| 2017 | -3.37 Million CAD | -85.23% |
| 2016 | -2.16 Million CAD | 12.89% |
| 2015 | -993.6 Thousand CAD | 3.25% |
| 2014 | -1.41 Million CAD | 36.78% |
| 2013 | -1.12 Million CAD | 33.13% |
| 2012 | -3.68 Million CAD | -21.7% |
| 2011 | -2.85 Million CAD | -75.48% |
| 2010 | -3.65 Million CAD | -43.34% |
| 2009 | -1.73 Million CAD | 68.06% |
| 2008 | -4.5 Million CAD | -219.63% |
| 2007 | -1.47 Million CAD | -3621.58% |
| 2006 | -992.29 Thousand CAD | 59.47% |
| 2005 | -103.56 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.15 Million CAD | -1.74% |
| 2024 Q2 | -1.36 Million CAD | -17.62% |
| 2023 Q1 | -1.34 Million CAD | -30.25% |
| 2023 FY | - CAD | -2.75% |
| 2023 Q3 | -1.13 Million CAD | -5.32% |
| 2023 Q4 | -1.22 Million CAD | -8.0% |
| 2023 Q2 | -1.07 Million CAD | 20.08% |
| 2022 Q1 | -985.28 Thousand CAD | 13.73% |
| 2022 Q3 | -1.41 Million CAD | -7.34% |
| 2022 Q4 | -1.03 Million CAD | 27.03% |
| 2022 FY | - CAD | -33.66% |
| 2022 Q2 | -1.32 Million CAD | -33.99% |
| 2021 Q2 | -878.02 Thousand CAD | -9.56% |
| 2021 Q4 | -1.14 Million CAD | -58.56% |
| 2021 Q3 | -720.26 Thousand CAD | 17.97% |
| 2021 Q1 | -801.37 Thousand CAD | -59.91% |
| 2021 FY | - CAD | -122.69% |
| 2020 Q3 | -499.89 Thousand CAD | -97.25% |
| 2020 Q1 | -335.93 Thousand CAD | 42.81% |
| 2020 FY | - CAD | 49.22% |
| 2020 Q4 | -501.13 Thousand CAD | -0.25% |
| 2020 Q2 | -253.43 Thousand CAD | 24.56% |
| 2019 Q3 | -738.85 Thousand CAD | 9.0% |
| 2019 Q4 | -587.43 Thousand CAD | 20.49% |
| 2019 Q1 | -993.49 Thousand CAD | -6.39% |
| 2019 FY | - CAD | 17.44% |
| 2019 Q2 | -811.97 Thousand CAD | 18.27% |
| 2018 Q2 | -1.09 Million CAD | -22.78% |
| 2018 FY | - CAD | -17.72% |
| 2018 Q3 | -867.94 Thousand CAD | 20.92% |
| 2018 Q4 | -933.81 Thousand CAD | -7.59% |
| 2018 Q1 | -893.95 Thousand CAD | 4.94% |
| 2017 Q3 | -1.15 Million CAD | -71.47% |
| 2017 Q2 | -672.78 Thousand CAD | -40.84% |
| 2017 Q1 | -477.69 Thousand CAD | -385.85% |
| 2017 FY | - CAD | -85.23% |
| 2017 Q4 | -940.4 Thousand CAD | 18.48% |
| 2016 FY | - CAD | 12.89% |
| 2016 Q2 | -632.83 Thousand CAD | -9.76% |
| 2016 Q1 | -576.54 Thousand CAD | 8.29% |
| 2016 Q4 | -98.32 Thousand CAD | 77.91% |
| 2016 Q3 | -445.01 Thousand CAD | 29.68% |
| 2015 FY | - CAD | 3.25% |
| 2015 Q2 | -493.23 Thousand CAD | -9.08% |
| 2015 Q4 | -628.65 Thousand CAD | -78.01% |
| 2015 Q3 | -353.15 Thousand CAD | 28.4% |
| 2015 Q1 | -452.18 Thousand CAD | 41.04% |
| 2014 FY | - CAD | 36.78% |
| 2014 Q3 | -557.67 Thousand CAD | -39.99% |
| 2014 Q1 | -317.68 Thousand CAD | 66.66% |
| 2014 Q2 | -398.35 Thousand CAD | -25.39% |
| 2014 Q4 | -766.95 Thousand CAD | -37.53% |
| 2013 Q4 | -952.78 Thousand CAD | -22.94% |
| 2013 FY | - CAD | 33.13% |
| 2013 Q2 | -722.63 Thousand CAD | 11.29% |
| 2013 Q1 | -814.6 Thousand CAD | 43.16% |
| 2013 Q3 | -775.03 Thousand CAD | -7.25% |
| 2012 Q2 | -1.05 Million CAD | 6.17% |
| 2012 Q4 | -1.43 Million CAD | -8.88% |
| 2012 FY | - CAD | -21.7% |
| 2012 Q1 | -1.12 Million CAD | -20.77% |
| 2012 Q3 | -1.31 Million CAD | -24.63% |
| 2011 Q3 | -1.06 Million CAD | -12.54% |
| 2011 Q1 | -832 Thousand CAD | -14.5% |
| 2011 Q2 | -943.33 Thousand CAD | -13.38% |
| 2011 FY | - CAD | -75.48% |
| 2011 Q4 | -932.11 Thousand CAD | 12.2% |
| 2010 Q3 | -773.74 Thousand CAD | -32.55% |
| 2010 Q1 | -211.53 Thousand CAD | 49.89% |
| 2010 Q4 | -726.65 Thousand CAD | 6.09% |
| 2010 FY | - CAD | -43.34% |
| 2010 Q2 | -583.72 Thousand CAD | -175.94% |
| 2009 FY | - CAD | 68.06% |
| 2009 Q4 | -422.12 Thousand CAD | -89.03% |
| 2009 Q1 | -683.61 Thousand CAD | 61.81% |
| 2009 Q2 | -402.92 Thousand CAD | 41.06% |
| 2009 Q3 | -223.3 Thousand CAD | 44.58% |
| 2008 Q3 | -1.22 Million CAD | -12.2% |
| 2008 Q2 | -1.09 Million CAD | -33.84% |
| 2008 Q1 | -816.5 Thousand CAD | 1.3% |
| 2008 FY | - CAD | -219.63% |
| 2008 Q4 | -1.79 Million CAD | -45.99% |
| 2007 Q3 | -337.88 Thousand CAD | -5929.93% |
| 2007 Q1 | -45.72 Thousand CAD | -41.77% |
| 2007 FY | - CAD | -3621.58% |
| 2007 Q4 | -827.25 Thousand CAD | -144.83% |
| 2007 Q2 | -5603.53 CAD | 87.75% |
| 2006 Q1 | -9992.07 CAD | 0.0% |
| 2006 Q3 | 1810.01 CAD | 217.97% |
| 2006 Q2 | -1534.25 CAD | 84.65% |
| 2006 Q4 | -32.25 Thousand CAD | -1882.07% |
| 2006 FY | - CAD | 59.47% |
| 2005 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -17.91 Million CAD | 73.555% |
| Therma Bright Inc. | -3.67 Million CAD | -28.807% |
| Theralase Technologies Inc. | -4.25 Million CAD | -11.386% |